EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory and neutrophil extracellular trap markers to predict cardiac events after ST-segment elevation myocardial infarction

Ana Blasco iD, Axel Rosell, Raquel Castejón, Ana Royuela, Charlotte Thålin, Elvira Ramil, Silvia Elorza, María-José Coronado, Paloma Martín, Javier Vázquez, Carolina González-Andrés, Juan M Escudier und 2 weitere

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0319759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Ana Blasco und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Hauptthemen laut MEDLINE: Extracellular Traps, ST Elevation Myocardial Infarction, Inflammation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Sociedad Española de Cardiología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Inflammation plays a pivotal role in the pathophysiology of ST-elevation myocardial infarction (STEMI). This involves neutrophil activation and the local release of pro-inflammatory mediators. The formation of neutrophil extracellular traps (NETs) in coronary thrombosis has been linked to poor short-term prognosis following STEMI, but the usefulness of specific circulating NET components as prognostic markers is unclear. We aimed to evaluate the NET-specific marker nucleosomal citrullinated histone H3 (H3Cit-DNA) and other classical inflammatory markers to predict adverse events after STEMI.

Methods

This is a single-center retrospective cohort study of patients with STEMI undergoing primary percutaneous coronary intervention (PCI) from 2015 to 2019. We analyzed the association between serum H3Cit-DNA levels, double-stranded DNA, and classical inflammatory markers –such us interleukin (IL) 6 and 1β, TNF-α, and C-reactive protein (CRP)– on admission and the occurrence of major cardiovascular events (MACE), including death, reinfarction, urgent revascularization, or heart failure, after STEMI.

Results

A total of 487 patients were studied, of which 380 were men [78%]; mean [SD] age of patients was 63 [13] years, and median [95%CI] follow-up was 5.4 [5.2-5.5] years. Median [IQR] H3Cit level was 179.30 [105.30-281.47] ng/ml. No relevant association was found between H3Cit-DNA levels and 30-day mortality (OR, 1.03 [95%CI, 0.71-1.50], p = 0.861) or MACE (0.98 [0.72-1.32], p = 0.879), Killip class (0.95 [0.74-1.21], p = 0.664), or left ventricular ejection fraction (ref.cat. > 50%; < 35%, RRR 1.01 [95%CI, 0.74-1.38], p = 0.952; 35-50%, 1.26 [1.07-1.48], p = 0.005]. Adding CRP and IL-6 levels as covariates to a model based on classical risk factors significantly improved the prediction of MACE at 30 days after STEMI (IDI 0.13; NRI 0.32, p < 0.05).

Conclusions

Circulating levels of the NET marker H3Cit-DNA at the time of primary PCI were not predictive of cardiovascular events following STEMI. In contrast, the classical inflammatory markers CRP and interleukin-6 significantly enhanced the discriminative capacity of a clinical 30-day risk prediction model. These findings suggest that measuring circulating NET-specific markers may have limited utility in assessing the inflammatory state during the early stages of STEMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular TrapsST Elevation Myocardial InfarctionInflammationHumansMaleFemaleMiddle AgedBiomarkersRetrospective StudiesAgedPercutaneous Coronary InterventionHistonesPrognosisC-Reactive Protein

Substanzen

BiomarkersHistonesC-Reactive Protein

Autor:innen und Institutionen

  • Cardiology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Research Ethics Committee, Instituto de Investigación Puerta de Hierro-Segovia de Arana, Madrid, Spain.
  • Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Internal Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Biostatistics Unit, Instituto de Investigación Puerta de Hierro-Segovia de Arana, Madrid, Spain.

ORCID-Profile: Ana Blasco

Förderung

  • Instituto de Salud Carlos III
  • Sociedad Española de Cardiología

Zitieren

APA

Blasco, A., Rosell, A., Castejón, R., Royuela, A., Thålin, C., Ramil, E., Elorza, S., Coronado, M. J., Martín, P., Vázquez, J., González-Andrés, C., Escudier, J. M., Ortega, J., & Bellas, C. (2025). Inflammatory and neutrophil extracellular trap markers to predict cardiac events after ST-segment elevation myocardial infarction. PLOS ONE. https://doi.org/10.1371/journal.pone.0319759

Vancouver

Blasco A, Rosell A, Castejón R, Royuela A, Thålin C, Ramil E, et al. Inflammatory and neutrophil extracellular trap markers to predict cardiac events after ST-segment elevation myocardial infarction. PLOS ONE. 2025. doi:10.1371/journal.pone.0319759

BibTeX
@article{Blasco2025,
  author = {Blasco, Ana and Rosell, Axel and Castejón, Raquel and Royuela, Ana and Thålin, Charlotte and Ramil, Elvira and Elorza, Silvia and Coronado, María-José and Martín, Paloma and Vázquez, Javier and González-Andrés, Carolina and Escudier, Juan M and Ortega, Javier and Bellas, Carmen},
  title = {Inflammatory and neutrophil extracellular trap markers to predict cardiac events after ST-segment elevation myocardial infarction},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0319759}
}
Kostenlos starten →